Lilly Asia Ventures Fund III L.P. 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-06 3:02 pm Sale | 2022-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 0 0.000% | -1,704,391 (Position Closed) | Filing |
| 2022-02-09 12:20 pm Sale | 2021-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 1,704,391 6.200% | -384,468 (-18.41%) | Filing |
| 2020-02-13 5:25 pm Purchase | 2019-12-31 | 13G | NextCure, Inc. NXTC | Lilly Asia Ventures Fund III L.P. | 2,088,859 7.800% | 2,088,859 (New Position) | Filing |